Keftab
Keftab Price range: $ 41,00 through $ 593,00
Back to products
Keppra
Keppra Price range: $ 71,00 through $ 486,00

Kemadrin

Price range: $ 41,00 through $ 281,00

Kemadrin is an effective anticholinergic medication primarily used to manage symptoms associated with various forms of Parkinson’s disease. It works by helping to balance chemical substances in the brain, which significantly improves muscle control and reduces stiffness. Patients often use this treatment to relieve tremors, muscle spasms, and poor muscle coordination. In addition to Parkinson’s, Kemadrin is highly effective in controlling movement disorders caused by certain psychiatric medications. By restoring physical mobility, this medication helps individuals maintain a more active and comfortable daily lifestyle.

Active substance: procyclidine
SKU: Kemadrin Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Kemadrin – Information for Patients and Caregivers

Kemadrin belongs to a class of medications known as central anticholinergic agents. It is prescribed under federal regulatory oversight for the clinical management of motor symptoms associated with parkinsonism and extrapyramidal movement disorders induced by neuroleptic therapy.

This prescription medication requires appropriate diagnostic evaluation, individualized dosage adjustment, and routine medical supervision. A comprehensive understanding of its pharmacological mechanisms, pharmacokinetic properties, potential adverse reactions, and safe administration guidelines supports optimal therapeutic oversight.

Parameter Clinical Details
Active ingredient (INN) Procyclidine hydrochloride
Therapeutic class Anticholinergic / Antiparkinsonian agent
Dosage form Oral tablet
Primary purpose Symptomatic relief of parkinsonism and drug-induced extrapyramidal symptoms
Prescription status Prescription (Rx) only

How the drug works

The active substance in Kemadrin, procyclidine hydrochloride, acts primarily as a central muscarinic acetylcholine receptor antagonist. In physiological state, normal basal ganglia function relies on a delicate neurochemical balance between inhibitory dopaminergic pathways and excitatory cholinergic pathways. In neurodegenerative conditions like Parkinson’s disease, loss of dopaminergic input leads to relative cholinergic overactivity within the striatum.

By competitively blocking central muscarinic receptors, procyclidine diminishes excessive cholinergic transmission. This mechanism aids in alleviating rigidity, tremor, and sialorrhea. Furthermore, procyclidine exhibits a peripheral atropine-like spasmolytic activity on smooth muscle structures, which contributes to its secondary peripheral pharmacological effects.

Main uses

Kemadrin is indicated as an adjunct in the treatment of all forms of parkinsonism, including idiopathic Parkinson’s disease, postencephalitic parkinsonism, and arteriosclerotic parkinsonism. It assists in diminishing muscle stiffness, resting tremor, and overall motor impairment associated with these conditions.

In clinical practice, Kemadrin is also widely indicated for the control of extrapyramidal symptoms brought on by central nervous system depressants, specifically neuroleptic or antipsychotic drugs. These drug-induced side effects include acute dystonia, akathisia, and pseudoparkinsonism. The choice to initiate therapy relies on a physician’s evaluation of symptom severity and underlying patient history.

How it’s absorbed and eliminated

Following oral administration, procyclidine hydrochloride is readily absorbed from the gastrointestinal tract. Clinical onset of central anticholinergic activity typically occurs within 30 to 60 minutes after ingestion, reaching peak systemic concentrations within 1 to 2 hours.

The drug undergoes extensive hepatic metabolism into structural metabolites before renal clearance. The elimination half-life of procyclidine ranges approximately from 10 to 12 hours, though individual pharmacokinetic variations may occur based on age, hepatic function, and renal status. Excretion occurs predominantly via the urinary route in the form of metabolic conjugates and unaltered substance.

Dosing schedule

The therapeutic dosage of Kemadrin must be individualized by a prescribing provider to achieve adequate symptomatic control while minimizing anticholinergic side effects. Treatment is generally initiated at lower dosages, such as 2.5 mg administered three times daily after meals, with gradual increments depending on clinical response.

When used to treat drug-induced extrapyramidal symptoms, doses are titrated until motor stability is established. Oral administration immediately following meals helps mitigate potential gastric discomfort. Dose reductions or discontinuation of Kemadrin should always occur gradually under direct medical supervision to prevent rebound cholinergic symptoms.

Adverse reactions

The safety profile of Kemadrin is largely governed by its central and peripheral antimuscarinic actions. The frequency and intensity of adverse reactions are often dose-dependent. Commonly reported peripheral anticholinergic manifestations include dryness of the mouth (xerostomia), blurred vision due to mydriasis and loss of accommodation, constipation, and urinary hesitancy or retention.

Central nervous system side effects may encompass dizziness, lightheadedness, impaired memory, disorientation, and mild drowsiness. In elderly patients or individuals receiving higher doses, severe central effects such as confusion, agitation, visual hallucinations, and acute delirium may arise. Cardiovascular manifestations can include transient tachycardia or palpitations.

Compatibility with other medicines

Concomitant administration of Kemadrin with other agents possessing anticholinergic properties–such as tricyclic antidepressants, first-generation antihistamines, phenothiazines, and certain antiarrhythmic agents–may produce additive antimuscarinic side effects, increasing the risk of severe dry mouth, paralytic ileus, or acute urinary retention.

Additionally, drugs that slow gastrointestinal motility may alter the absorption kinetics of co-administered oral medications. Procyclidine may oppose the pharmacological effects of parasympathomimetic agents and acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine). Patients must disclose all prescription, over-the-counter, and dietary supplement therapies to their prescribing physician to avoid unfavorable interactions.

Important precautions

Kemadrin requires careful risk evaluation prior to initiation, particularly in individuals with pre-existing medical conditions. The medication is generally contraindicated or requires extreme caution in patients with narrow-angle glaucoma, as pupillary dilation can precipitate acute intraocular pressure spikes. Patients with obstructive disorders of the gastrointestinal tract or severe prostatic hyperplasia should be carefully monitored due to risks of bowel obstruction and acute urinary retention.

Special caution is warranted when prescribing to elderly patients. Geriatric individuals exhibit heightened sensitivity to central anticholinergic effects, increasing their susceptibility to cognitive decline, acute confusion, and falls. Patients with severe cardiovascular disease, including unstable angina or tachyarrhythmias, require close ongoing assessment.

What to avoid while taking it

Central nervous system depressants, including alcohol, can amplify the sedative and cognitive-impairing effects of procyclidine. Patients taking Kemadrin should avoid alcohol consumption during treatment to prevent severe drowsiness, impaired motor coordination, and altered judgment.

Because anticholinergic agents suppress sweat gland activity, patients should avoid prolonged exposure to high ambient temperatures or strenuous exercise in hot climates. Reduced sweating impairs normal thermoregulation, escalating the risk of hyperthermia and heat stroke.

If you skip a dose

If a dose of Kemadrin is missed, it should be taken as soon as remembered, provided it is taken with food if gastric sensitivity exists. However, if the time is close to the next scheduled dose, the missed dose should be omitted entirely, resuming the regular dosing schedule.

Patients must never take a double dose to compensate for a missed tablet. Abruptly doubling the dosage increases the incidence of severe antimuscarinic toxicity, including acute visual disturbances and urinary obstruction.

Red flags

Immediate emergency medical evaluation is required if any of the following severe signs or symptoms develop during Kemadrin therapy:

  • Sudden, severe eye pain, accompanied by blurred vision, red eye, or halos around lights (suggestive of narrow-angle glaucoma attack).
  • Complete inability to urinate or severe pain in the lower abdomen due to bladder distension.
  • Severe mental status changes, including vivid visual hallucinations, profound confusion, extreme restlessness, or delirium.
  • Signs of hypersensitivity, including swelling of the face, lips, tongue, or throat, or sudden difficulty breathing.
  • Unusually rapid, pounding, or irregular heartbeat accompanied by lightheadedness or syncope.

Practical tips

To manage dry mouth associated with Kemadrin, maintaining adequate hydration, practicing frequent oral hygiene, and using sugarless hard candies or oral lubricants may provide symptomatic relief. Patients experiencing visual blurring should avoid driving, operating machinery, or performing hazardous tasks until their vision clears.

Using sunglasses can reduce light sensitivity caused by dilated pupils. Elderly individuals taking Kemadrin should move slowly when standing up from sitting or lying positions to reduce the likelihood of postural dizziness.

Common questions

Can Kemadrin be stopped suddenly if symptoms disappear?

Kemadrin should not be discontinued abruptly. Sudden cessation of anticholinergic therapy can trigger a rebound exacerbation of parkinsonian symptoms, severe muscular rigidity, or symptoms of cholinergic overdrive such as excessive sweating, nausea, and anxiety. A prescribing physician will provide a gradual dose-tapering schedule when treatment discontinuation is indicated.

How does Kemadrin affect driving and machinery operation?

Kemadrin frequently causes drowsiness, dizziness, and accommodation disturbances leading to blurred vision. These adverse effects compromise reaction time and visual acuity, making activities such as operating motor vehicles or operating heavy machinery hazardous. Individuals should refrain from such activities until the specific personal reaction to the medication is fully established.

Is Kemadrin suitable for managing symptoms during pregnancy?

Clinical data regarding the safe use of procyclidine hydrochloride during pregnancy are limited. Prescribers evaluate Kemadrin during pregnancy only if the prospective clinical benefits outweigh the potential risks to the developing fetus. Female patients should inform their healthcare provider immediately if pregnancy is suspected or planned.

Can Kemadrin be taken on an empty stomach?

While procyclidine can be absorbed on an empty stomach, taking Kemadrin immediately after meals or with food is generally recommended. Food co-administration minimizes gastrointestinal side effects such as nausea or stomach upset without significantly compromising systemic drug availability.

What happens if an accidental overdose of Kemadrin occurs?

An overdose of Kemadrin leads to severe anticholinergic toxicity, characterized by severe dry mouth, hyperthermia, dilated unresponsive pupils, extreme tachycardia, urinary retention, agitation, hallucinations, and respiratory depression. Accidental ingestion of doses higher than prescribed demands immediate emergency medical intervention or contact with a regional poison control center.

In accordance with FDA requirements.

This content is informational and does not replace a consultation with your doctor or pharmacist.

Additional information
Dosage

5mg

Package

30 pills

,

60 pills

,

90 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία